Trial Details

COMPLETED
Basic Information
Clinical ID c1828
Identifier NCT03750565
Trial Title Multiple Dose Ethnobridging PK Study in Healthy Subjects
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases; IBD
Interventions DRUG: TD-1473 - Dose A; DRUG: TD-1473 - Dose B; DRUG: TD-1473 - Dose C; DRUG: Placebo
Participant Information
Sponsor Theravance Biopharma
City Cypress
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2018-11-27
Primary Completion Date 2019-02-13
Completion Date 2019-02-13